Loading clinical trials...
Loading clinical trials...
Efficacy Study of Oral Collagen Peptide on Skin Conditions
To assess if oral intake of collagen peptide can improve skin conditions such as skin thickness, density and firmness.
This is an one site, randomized, double-blind controlled clinical trial to assess the oral supplement of LISAVEI collagen peptide solid beverage on skin ageing improvement. Study product with collagen peptide and placebo product without collagen were randomly assigned to 90 eligible participants enrolled according to the inclusion and exclusion criteria. They took the assigned product once daily dissolved in 100 ml warm water for 12 weeks with 4-week regression phase(without intake of the test products), and visit the study site in Shanghai for four times(before starting the treatment, after 8 and 12 weeks, and 4 weeks after the last intake). Skin measurements including skin firmness, skin density, skin hydration and skin barrier were carried out at each visit with professional equipment and imaging system. Data were analyzed to validate if the administration of the test collagen peptide solid beverage will improve skin aging parameters such as firmness, thickness, density, hydration and skin barrier compared to placebo. The lasting effect was also observed by comparing between the two groups after 4-week regression time.
Age
35 - 55 years
Sex
FEMALE
Healthy Volunteers
No
Shanghai Fumei Dermatology Clinic
Shanghai, Shanghai Municipality, China
Start Date
July 25, 2024
Primary Completion Date
November 19, 2024
Completion Date
November 19, 2024
Last Updated
February 28, 2025
90
ACTUAL participants
Active Comparator
DIETARY_SUPPLEMENT
Placebo Comparator
DIETARY_SUPPLEMENT
Lead Sponsor
Shanghai Meifute Biotechnology Co., Ltd
NCT07261748
NCT06804759
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07486414